Today we’re excited to announce that the U.S. Food and Drug Administration (FDA) has selected our cloud content management platform to modernize its technical infrastructure and drive new ways to work in the cloud. With Box, the FDA is furthering its IT innovation strategy to digitize business processes and envision new ways to engage with the pharmaceutical and life sciences industry.
The FDA is leading the way on how government agencies are leveraging modern technology to better engage with stakeholders and improve mission outcomes. The FDA’s investment in a cloud strategy, including partnerships with companies like Box, is poised to help the agency re-imagine stakeholder engagement, build digital experiences, and bring agility to mission delivery, while ensuring the privacy and security of sensitive data. We are thrilled to support the FDA mission, helping to transform the way they manage and share information.
FDA IT leadership, tasked with modernizing its technology infrastructure and re-imagining how the FDA works with the life sciences industry, selected Box to:
- Improve external collaboration with third party organizations, including external experts, and supporting audits, discoveries and reviews.
- Digitize and automate processes leveraging Box as a central content portal where staff can easily collaborate and share materials internally and with external parties.
- Reduce complexity of infrastructure by eliminating fragmented content and document management tools.
- Provide the FDA with added cybersecurity control and administrative capabilities necessary to govern and protect sensitive information at scale.
This is an incredibly important partnership for us not only because we are helping the FDA become more efficient, streamlined and agile, but because it represents our continued commitment and investment in helping to transform the life sciences industry. Today, we power cloud content management for more than 650 life sciences organizations, including 12 of the top 15 global pharmaceutical companies like Amgen, AstraZeneca, Eli Lilly and GlaxoSmithKline. By empowering the FDA to work in new ways and significantly improving the collaboration and communication with the life sciences industry, our pharmaceutical customers will be able to bring important drugs to market faster – helping them save lives and achieve their missions.
Box makes it easy for more than 76,000 organizations around the world to share, access, and collaborate securely on their most important content. With today’s announcement, the FDA joins leading global organizations that have moved to Box to power new ways of working, including the DOJ, the District of Columbia Government, GE and Procter & Gamble.